Progressive brain volume changes and the clinical course of schizophrenia in men: A longitudinal magnetic resonance imaging study

Archives of General Psychiatry

Volumn 58, Issue 2, 2001, Pages 148-157

  Mathalon, D H ^a   Sullivan, E V ^a   Lim, K O ^a   Pfefferbaum, A ^a  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAIN SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; HUMAN; LONGITUDINAL STUDY; MALE; MENTAL DISEASE; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; SCHIZOPHRENIA;

EID: 0035134442     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.58.2.148     Document Type: Article

References (95)

1. X-ray computerized tomography studies in schizophrenia: A review and synthesis
2. Neuroimaging in neuropsychiatric disorders
3. A review of magnetic resonance imaging studies of brain abnormalities in schizophrenia
4. Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia
5. Cortical gray matter volume deficit in patients with first-episode schizophrenia
6. Brain morphology in first-episode schizophrenia
7. Implications of normal brain development for the pathogenesis of schizophrenia
8. Three-year follow-up of older schizophrenics: Extrapyramidal syndromes, psychiatric symptoms, and ventricular brain ratio
9. Stability of CT scan findings in schizophrenia: Results of an 8 year follow-up study
10. Cerebral ventricular enlargement in schizophrenia: A preliminary follow-up study
11. Stability of ventricular size after the onset of psychosis in schizophrenia
12. Brain morphology in schizophrenia: A 2- to 5-year CT scan follow-up study
13. Ventricle-to-brain ratio in schizophrenia: A controlled follow-up study
14. Progressive ventricular enlargement in schizophrenia: Comparison to bipolar affective disorder and correlation with clinical course
15. Follow up MRI study in first episode schizophrenia
16. The timing of brain morphological changes in schizophrenia and their relationship to clinical outcome
17. Cerebral ventricular enlargement in schizophreniform disorder does not progress: A seven year follow-up study
18. Psychobiologic correlates of treatment response in schizophrenia
19. Stability of cerebral ventricular size from the appearance of the first psychotic symptoms to the later diagnosis of schizophrenia
20. Childhood-onset schizophrenia: Brain MRI rescan after 2 years of clozapine maintenance treatment
21. Progression of cerebroventricular enlargement and the subtyping of schizophrenia
22. A prospective follow-up study of brain morphology and cognition in 1st episode schizophrenic patients: Preliminary findings
23. Schizophrenia as a chronic active brain process: A study of progressive brain structural change subsequent to the onset of schizophrenia
24. Ventricular enlargement in poor-outcome schizophrenia
25. Childhood-onset schizophrenia: Progressive ventricular change during adolescence
26. Progressive cortical change during adolescence in childhood-onset schizophrenia: A longitudinal magnetic resonance imaging study
27. Childhood-onset schizophrenia: Progressive brain changes during adolescence
28. A follow-up magnetic resonance imaging study of schizophrenia: Relationship of neuroanatomical changes to clinical and neurobehavioral measures
29. Progressive reduction of temporal lobe structures in childhood-onset schizophrenia
30. A profile of cortical gray matter volume deficits characteristic of schizophrenia
31. A controlled study of cortical gray matter and ventricular changes in alcoholic men over a 5-year interval
32. Is schizophrenia a progressive neurodevelopmental disorder? towards a unitary pathogenetic mechanism
33. Is schizophrenia a neurodegenerative disorder? a clinical and neurobiological perspective
34. A selective review of recent North American long-term followup studies of schizophrenia
35. Regional brain volume change over the life-time course of schizophrenia
36. Progressive changes in schizophrenia: Do they exist and what do they mean?
37. Neuroleptics and the natural course of schizophrenia
38. Duration of psychosis and outcome in first-episode schizophrenia
39. The structured clinical interview for DSM-III-R (SCID): History, rationale, and description
40. A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood
41. Brain gray and white matter volume loss accelerates with aging in chronic alcoholics: A quantitative MRI study
42. A diagnostic interview: The Schedule for Affective Disorders and Schizophrenia
43. Mini-mental state: A practical method for grading the cognitive state of patients for the clinician
44. Group test for assessing hand and eye dominance
45. The Brief Psychiatric Rating Scale (BPRS): Recent developments in ascertainment and scaling
46. The Brief Psychiatric Rating Scale (BPRS): A comprehensive review
47. Segmentation of MR brain images into cerebrospinal fluid spaces, white and gray matter
48. Longitudinal volumetric computed tomographic analysis of regional brain changes in normal aging and Alzheimer's disease
49. Longitudinal changes in magnetic resonance imaging brain volumes in abstinent and relapsed alcoholics
50. Brain morphology in first-episode schizophrenic-like psychotic patients: A quantitative magnetic resonance imaging study
51. Left ventricular enlargement associated with diagnostic outcome of schizophreniform disorder
52. Widespread cerebral gray matter volume deficits in schizophrenia
53. Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia
54. Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging
55. "Cognitive dysmetria" as an integrative theory of schizophrenia: A dysfunction in cortical-subcortical-cerebellar circuitry?
56. Neural circuits in schizophrenia
57. Neural circuits in schizophrenia
58. Schizophrenia: A disease of heteromodal association cortex?
59. Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: A search for common ground
60. Frontal and temporal lobe brain volumes in schizophrenia: Relationship to symptoms and clinical subtype
61. Limbic-cortical neuronal damage and the pathophysiology of schizophrenia
62. Dysfunctions in multiple interrelated systems as the neurobiological bases of schizophrenic symptom clusters
63. Glutamate receptor dysfunction and schizophrenia
64. A randomised controlled trial of prophylactic neuroleptic treatment
65. Early intervention with neuroleptics may decrease the long-term morbidity of schizophrenia
66. Time course of cerebral ventricular enlargement in schizophrenia supports the hypothesis of its neurodevelopmental nature
67. On the plausibility of "the neurodevelopmental hypothesis" of schizophrenia
68. Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics
69. Gliosis in schizophrenia: A survey
70. Measurement of the alpha-cell migration in the entorhinal region: A marker for the developmental disturbances in schizophrenia
71. Neuropathology of schizophrenia
72. Glial fibrillary acidic protein-immunoreactive astrocytosis in elderly patients with schizophrenia and dementia
73. Fibrin degradation products in post mortem brain tissue of schizophrenics: A possible marker for underlying inflammatory processes
74. The neuropathology of schizophrenia: A critical review of the data and their interpretation
75. Programmed cell death: Implications for neuropsychiatric disorders
76. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics
77. Abnormally high neuronal density in the schizophrenic cortex: A morphometric analysis of prefrontal area 9 and occipital area 17
78. MRI anatomy of schizophrenia
79. N-methyl-D-aspartate receptor hypofunction in schizophrenia could arise from reduced cortical connectivity rather than receptor dysfunction: Reply
80. The glutamatergic dysfunction hypothesis for schizophrenia
81. Stress effects on morphology and function of the hippocampus
82. Long-term followup studies of schizophrenia
83. Catamnestic long-term study on the course of life and aging of schizophrenia
84. Dementia in elderly schizophrenic patients: Clinical and neurological correlates
85. Deficit syndrome in older schizophrenic patients
86. Clinical neuropsychological findings in schizophrenia and aging
87. The dementia of dementia praecox
88. Age disorientation in chronic schizophrenia is associated with global intellectual impairment
89. The positive-negative distinction in schizophrenia: Review of natural history validators
90. Severe cognitive impairment in elderly schizophrenic patients: Clinicopathological study
91. Neuroimaging and the cognitive neuroscience of schizophrenia